Cargando…
Association between β2-Adrenoreceptor Medications and Risk of Parkinson’s Disease: A Meta-Analysis
Background and Objective: Parkinson’s disease (PD) is a progressive neurological disorder characterized by an accumulation of Lewy bodies and degeneration of dopaminergic neurons in the substantia nigra. The treatment options currently available are only partly effective and fail to restore the lost...
Autores principales: | Chen, Chu-Ling, Wang, Shu-Yi, Chen, Ta-Cheng, Chuang, Chieh-Sen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541298/ https://www.ncbi.nlm.nih.gov/pubmed/34684044 http://dx.doi.org/10.3390/medicina57101006 |
Ejemplares similares
-
Antidiabetic Agents for Treatment of Parkinson’s Disease: A Meta-Analysis
por: Wang, Shu-Yi, et al.
Publicado: (2020) -
MRI Assessment of Cardiomyopathy Induced by β1-Adrenoreceptor Autoantibodies and Protection Through β3-Adrenoreceptor Overexpression
por: Vanhoutte, Laetitia, et al.
Publicado: (2017) -
Spotlight on ROS and β3-Adrenoreceptors Fighting in Cancer Cells
por: Calvani, Maura, et al.
Publicado: (2019) -
ß-Adrenoreceptors in Human Cancers
por: Kraboth, Zoltan, et al.
Publicado: (2023) -
Mirabegron, a β3‑adrenoreceptor agonist, regulates right and left atrial arrhythmogenesis differently
por: Chan, Chao-Shun, et al.
Publicado: (2022)